July 26, 2008 |
Amgen Inc. said its experimental osteoporosis drug denosumab reduced fractures in women with the bone-thinning disease in a study. The trial of 7,800 women with osteoporosis found that denosumab strengthened bones and reduced spinal and hip fractures, the Thousand Oaks-based company said.
July 23, 1987
The Southern California chapter of the Arthritis Foundation has awarded a $60,000 grant to UCLA endocrinologist Theodore Hahn for a study on rheumatoid arthritis and osteoporosis. Rheumatoid arthritis patients are at high risk at an early age for osteoporosis, a dangerous thinning of the bones, officials said.
April 20, 2000 |
The Food and Drug Administration cleared a Beckman Coulter Inc. blood test as an aid in managing osteoporosis and Paget's disease, the Fullerton company said Wednesday. The new Access Ostase test gives physicians and patients a more timely method to evaluate therapy to help prevent or treat osteoporosis, a disease that weakens the bones, and Paget's disease, a crippling bone disorder, the company said. The company's stock closed Wednesday at $63.
October 12, 1995 |
What's new in the treatment of osteoporosis? * Fosamax. Approved last week, Fosamax is the first new drug for osteoporosis in 20 years. The drug, chemically known as alendronate, helps to increase bone density. * Calcitonin nasal spray. The hormone calcitonin, now available as an injectable medication, may soon be approved as a nasal spray. The medication helps slow the rate of bone loss. * Sodium fluoride.
December 16, 2002 |
Imagine going to the doctor's office once a year for treatment of a chronic medical condition. No daily pills. No weekly therapies. Just 30 minutes or so in a clinic. It could happen. A new osteoporosis drug called zoledronic acid has been shown to increase bone mineral density in rates similar to those achieved with medications taken daily or weekly.
April 3, 2008 |
Amgen Inc. said its experimental drug for osteoporosis boosted bone density among postmenopausal women in a clinical trial. The treatment, denosumab, was more effective than a placebo at increasing bone density in a study of 332 women, the Thousand Oaks-based company said.
January 13, 1989 |
An experimental treatment that promotes bone growth appears to strengthen the backbones of women who have suffered spinal fractures due to osteoporosis, researchers reported Thursday. The treatment involves giving patients a slow-release form of sodium fluoride--the compound dentists use to fight tooth decay--and calcium supplements, said Dr. Charles Y. C. Pak, chief of mineral metabolism at the University of Texas Southwestern Medical Center at Dallas.